Feedback / Questions
CP-383 - Tasca Therapeutics
https://www.businesswire.com/news/home/20241210585569/en/Tasca-Therapeutics-Launches-with-52-Million-Series-A-Financing-to-Develop-Small-Molecule-Inhibitors-for-Multiple-Oncology-Indications
Dec 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious